• Home
  • About Us
    • Company Overview
    • Management
    • Board of Directors
    • Advisors
    • Partnerships
    • Careers
  • Research & Development
    • Pipeline
    • Clinical Trials
    • Publications
  • Newsroom
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Data
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • Governance
      • Documents & Charters
      • Committee Composition
    • Shareholder Resources
      • Email Alerts
      • FAQs
  • Contact

Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.

Dec 14, 2020 | Press Releases

Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW NEW YORK and CUPERTINO, Calif., Dec. 14, 2020 — Reviva Pharmaceuticals Holdings, Inc., a Delaware corporation (“Reviva Holdings”), as the successor to Tenzing Acquisition...
Next Entries »

Recent Posts

  • Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
  • Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
  • Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
  • Reviva to Participate in the 2025 BIO CEO & Investor Conference
  • Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

Recent Comments

No comments to show.

CONTACT

Reviva Pharmaceuticals Holdings, Inc.
10080 N Wolfe Road, Suite SW3-200
Cupertino, CA 95014

Phone: +1.408.501.8881
Email: [email protected]

  • Follow
  • Follow
Sign Up for Email Alerts

SITE LINKS

  • Home
  • Investors
  • Newsroom
  • Privacy Policy
  • Contact
  • Sitemap

Our COMPANY

  • About us
  • Management
  • Board of Directors
  • Advisors
  • Partnerships
  • Careers

RESEARCH & DEVELOPMENT

  • Pipeline
  • Clinical Trials
  • Publications
Reviva Pharmaceuticals Holdings, Inc. ©2025.   All Rights Reserved.
We value your privacy. We use cookies and other technologies to keep the site reliable and secure, measure site performance, tailor your experience, and deliver up to date stock data and financial information. By using our site, you agree to our use of cookies as described in our Privacy Policy.AcceptPrivacy policy